Pascal Soriot, chief executive of AstraZeneca, believes that Dame Emma Walmsley, his opposite number at GlaxoSmithKline, should continue with her turnaround plansThe boss of AstraZeneca has urged Dame Emma Walmsley, the embattled chief executive of its rival GlaxoSmithKline, to stick to her guns in transforming the London-listed drugs group. Walmsley, 52, also pledged to continue leading the business. SponsoredHer strategy has faced criticism from Elliott Management, the activist investor that in April was revealed to have built a significant stake in the group. While the American hedge fund has voiced its support for the consumer separation, it has urged the board to consider a sale of the division. Pascal Soriot said

Source: The Times August 06, 2021 14:48 UTC